Rojas GA, Cervantes J, Decanini A, Hernández B

Idioma: Español
Referencias bibliográficas: 47
Paginas: 210-215
Archivo PDF: 56.12 Kb.

RESUMEN

En una revisión histórica a partir de 1784 cuando John Hunter practicó la primera ligadura de la vena femoral por tromboflebitis supurativa a la fecha. Han pasado 220 años, durante los cuales ha habido numerosos cambios en las técnicas interruptivas de la vena cava, desde la ligadura hasta el empleo actual de filtros temporales o removibles. Los autores presentan su experiencia, a lo largo de 34 años, en la interrupción quirúrgica de la vena cava como tratamiento o profilaxis del tromboembolismo pulmonar; inicialmente de 1969 a 1988 con el clip de Adams-DeWeese en 103 pacientes y después, de 1987 a 2003, con las tres generaciones del filtro de Greenfield en 198 pacientes.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Sigler L, Romero T, Meillon LA, Gutiérrez L, Aguirre GI, Esparza C. Tromboembolia pulmonar en autopsias en un periodo de 10 años. Rev Med IMSS (Mex) 1996; 34: 7-11.

2. Lindblad B, Eriksson A, Bergqvist D. Autopsy-verified pulmonary embolism in a surgical department: Analysis of the period from 1951 to 1988. Br J Surg 1991; 78: 849-852.

3. Hull RD, Raskob GE, Rosenbloom D, Lemaire J, Pineo GF et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med 1992; 152: 1589-1595.

4. Levine M, Gent M, Hirsh J, Leclerc J et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. N Engl J Med 1996; 334: 677-687.

5. Simonneau G, Sors H, Charbonnier B, Page Y, Laaban JP et al. A comparison of low molecular weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 1997; 337: 663-669.

6. Greenfield LJ, Proctor MC. Current indications for caval interruption: Should they be liberalized in view of improving technology. Semin Vasc Surg 1996; 9: 50-58.

7. Whitehill TA. Caval interruption methods: Comparison of options. Semin Vasc Surg 1996; 9: 59-69.

8. Adams JT, DeWeese JA. Partial interruption of the inferior vein cava with a new plastic clip. Surg Gynecol Obstet 1966; Nov: 1087-1088.

9. Eichelter P, Schenk W. Prophylaxis of pulmonary embolism. A new experimental approach with initial results. Arch Surg 1968; 97: 348.

10. Mobin-Uddin K, Smith PE, Martinez LD. A vein cava filter for the prevention of pulmonary embolism. Surg Forum 1967; 18: 209-211.

11. Greenfield LJ, McCurdy Jr, Brown PP, Elkins RC. A new intracaval filter permitting continued flow and resolution of emboli. Surgery 1973; 73: 599-606.

12. Rojas G, Enriquez E, Garmilla J, Gerson R, Varela M. Un nuevo filtro de Greenfield de titanio para la interrupción endovascular percutánea de la vena cava inferior. An Med Asoc Med Hosp ABC 1992; 37: 75-78.

13. Greenfield LJ, Proctor M.C. Endovascular methods for caval interruption. Semin Vasc Surg 1997; 10: 310-314.

14. Whitehill TA. Current vein cava filter devices and results. Semin Vasc Surg 2000; 13: 204-212.

15. Greenfield LJ, Proctor MC. Twenty-year clinical experience with the Greenfield filter. Cardiovasc Surg 1995; 3: 199-205.

16. Gutiérrez CR, Sánchez FC, Ramírez MJ, Sauma RS, Morales MC et al. Interrupción del flujo en la vena cava inferior por embolia pulmonar. Rev Mex Angiol 1995; 23: 38-42.

17. Rojas G, Cervantes J, Arcos L, Ponte R, Galicia JA. Empleo del filtro de Greenfield en posición suprarrenal. Cir Ciruj 1996; 64: 102-107.

18. Rojas G, Ponte R, Gerson R, Cervantes J, Florez C. Filtro de Greenfield en vena cava superior. Informe del primer caso reportado en la literatura nacional. Rev Mex Angiol 1997; 25: 93-97.

19. Rojas G, Cervantes J, Alvarez AC, Enriquez E, Ponte R et al. Cinco años de experiencia clínica con el filtro de Greenfield. Cir Ibero Amer (Madrid) 1994; 2: 94-99.

20. Stewart JR, Peyton JW, Crute SL, Greenfield LJ. Clinical results of suprarenal placement of the Greenfield vena cava filter. Surgery 1992; 92: 1-4.

21. Greenfield LJ, Chok J, Proctor MC, Sobel M, Shap S, Wingo J. Late results of suprarenal Greenfield vena cava filter placement. Arch Surg 1992; 127: 969-973.

22. Peyton JW, Stewart JR, Greenfield LJ, Crute SL. Hemodynamics and renal function following experimental suprarenal vena caval occlusion. Surg Gynecol Obstet 1992; 155: 37-42.

23. Tagliabue M, Merati I, Crivellaro M, Computarized tomography in the follow up of inferior vena cava filters. Radiol Med 1991; 82: 315-321.

24. Brenner DW, Brenner CJ, Scott J, Wehberg K, Granger JP, Schellhammer PF. Suprarenal Greenfield filter placement to prevent pulmonary embolus in patients with vena caval tumor thrombi. J Urol 1992; 147: 19-23.

25. Teodorescu V, Schonzer H. Management of thrombophlebitis in the prepartum period. A case report. J Cardiovasc Surg 1992; 33: 448-450.

26. Henke P, Varma M, Proctor M, Greenfield LJ. Suprarenal Greenfield vena caval filter placement. The Ann Arbor Experience. In: ST Yao J, Pearce WH. Modern vascular surgery. New York, NY: McGraw Hill, 2000.

27. Pomper SR, Lutchman G. The role of intracaval filters in patients with COPD and DVT. Angiology 1991; 42: 85-89.

28. Rohrer MJ, Scheidler MG, Wheeler B, Cutler BS. Extended indications for placement of an inferior vena cava filter. J Vasc Surg 1989; 10: 44-50.

29. Berry R, George J, Shaver W: Free-floating deep venous thrombosis. Ann Surg 1990; 211: 719-723.

30. Cohen J, Tenenbaum M, Citron M. Greenfield filter as primary therapy for deep venous thrombosis and/or pulmonary embolism in patients with cancer. Surgery 1991; 109: 12-15.

31. Chan A, Woodruff RK. Complications and failure of anticoagulation therapy in the treatment of venous thromboembolism in patients with disseminated malignancy. Aust NZJ Med 1992; 22: 119-122.

32. Rojas G, Gerson R, Cervantes J, Arcos L, Villalobos A, Ponte R. Trombosis venosa profunda y/o tromboembolismo pulmonar en el paciente oncológico. Rev Inst Nal Cancerol (Mex) 1996; 42: 92-96.

33. Ascani A, Radicchia S, Paraise P. Distribution and occlusiveness of thrombi in patients with surveillance detected deep vein trombosis after hip surgery. Thromb Haemost 1996; 75: 239-241.

34. Vaughn B, Knezevich S, Lombardi A, Mallory T. Use of the Greenfield filter to prevent fatal pulmonary embolism associated with total hip and knee arthroplasty. J Bone Joint Surg 1989; 71: 1542-1548.

35. Collins DN, Barnes CL, McCowan TC, Nelson CL, Carver DK et al. Vein cava filter use in orthopaedic trauma patients with recognized preoperative venous thromboembolic disease. J Orthop Trauma 1992; 6: 135-138.

36. Rogers FB, Shackford SR, Ricci MA. Routine prophylactic vena cava filter insertion in severly injured trauma patients decreases the incidence of pulmonary embolism. J Am Coll Surg 1995; 180: 641-647.

37. Khansarinia S, Dennis JW, Veldenz HC. Prophylactic Greenfield filter placement in selected high-risk trauma patients. J Vasc Surg 1995; 22: 231-236.

38. Leach TA, Pastena JA, Swan KG, Tikellis JI, Blackwood JM, Odom JW. Surgical prophylaxis for pulmonary embolism. Ann Surg 1994; 60: 292-295.

39. Winchell RJ, Hoyt DB, Walsh JC, Simons RK, Eastman AB. Risk factors associated with pulmonary embolism despite routine prophylaxis: Implications for improved protection. J Trauma 1994; 37: 600-606.

40. Alexander JJ, Yuhas JP, Piotrowski JJ. Is the increasing use of prophylactic percutaneous IVC filters justified? Am J Surg 1994; 168: 102-106.

41. Wakefield TW, Proctor M. Current Status of pulmonary embolism and venous thrombosis prophylaxis. Semin Vasc Surg 2000; 13: 171-181.

42. Ageno W, Turpie AG. Low molecular weight heparin in the treatment of pulmonary embolism. Semin Vasc Surg 2000; 13: 189-193.

43. Vogelzang RL. Removable nonpermanent vena cava filters. Current concepts and status. In: ST Yao J, Pearce WH. Modern vascular surgery. New York, NY: McGraw-Hill, 2000.

44. Decousus H, Leizorovicz AL, Parent F, Page Y, Tardy B et al. A clinical trial of vena cava filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 1998; 338: 409-415.

45. The Columbus Investigators. Low molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997; 337: 657-662.

46. Koopman MMV, for the Tasman Study Group. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular weight heparin administered at home. N Engl J Med 1996; 334: 682-687.

47. Hirsh J, Siragusa S, Cosmi B. Low molecular weight heparins (LMWH) in the treatment of patients with acute venous thromboembolism. Thromb Haemost 1995; 74: 360-363.